Financials
- Market Capitalization 36.38 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.27
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4134 | INCR Intercure Ltd. - ordinary shares | 4.95 USD | 0.00% | -6.95% | -3.32% | +203.68% | 54.13 M USD | ||
| 4257 | SCYX SCYNEXIS, Inc. - Common Stock | 4.03 USD | -1.23% | -20.98% | -16.91% | +391.46% | 40.10 M USD | ||
| 4298 | CPHI China Pharma Holdings, Inc. Common Stock | 0.84 USD | -2.33% | +27.27% | +7.69% | +27.06% | 36.14 M USD | ||
| 4360 | RMTI Rockwell Medical, Inc. - Common Stock | 7.64 USD | -3.17% | -4.74% | -3.90% | +570.18% | 30.79 M USD |